MARKET

BGLC

BGLC

Bionexus Gene La
NASDAQ
2.190
+0.010
+0.46%
Closed 17:09 03/11 EDT
OPEN
2.290
PREV CLOSE
2.180
HIGH
2.290
LOW
2.132
VOLUME
10.64K
TURNOVER
18.77K
52 WEEK HIGH
15.60
52 WEEK LOW
1.920
MARKET CAP
5.18M
P/E (TTM)
-1.7132
1D
5D
1M
3M
1Y
5Y
1D
Bionexus Gene Lab appoints Muthu Meyyappan as CCO, Fidelion
TipRanks · 21h ago
BioNexus Gene Lab appoints Muthu Meyyappan as Fidelion Diagnostics chief commercial officer
Reuters · 21h ago
Press Release: BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard(TM) MRD Platform
Dow Jones · 21h ago
12 Industrials Stocks Moving In Monday's Intraday Session
Benzinga · 2d ago
Weekly Report: what happened at BGLC last week (0302-0306)?
Weekly Report · 3d ago
Weekly Report: what happened at BGLC last week (0223-0227)?
Weekly Report · 03/02 09:01
*BioNexus Gene Lab: Chemrex's Bd Streamlined to Two Directors: Matthew L. Barsing, Chmn, and Angeline Chong >BGLC
Dow Jones · 02/23 13:34
*BioNexus Gene Lab Appoints Matthew Barsing as Chairman >BGLC
Dow Jones · 02/23 13:32
More
About BGLC
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

Webull offers BioNexus Gene Lab Corp stock information, including NASDAQ: BGLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BGLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BGLC stock methods without spending real money on the virtual paper trading platform.